Active Government Funding Opportunities

Mature cancer research with near-term clinical impact for military health systems. Supports studies including clinical trials addressing congressionally directed priorities in oncology.

DoD seeks innovative, high-risk cancer research concepts to advance treatment options and patient outcomes for Service Members and military beneficiaries. Preliminary data not required; creative thinking and untested ideas addressing unmet clinical needs are prioritized.

Accelerate cancer treatment breakthroughs through clinical trials testing new drugs, devices, and emerging therapies. This award funds rapid-cycle trials from proof-of-concept to phase III, addressing the urgent need to translate promising cancer interventions into patient care.

Develop and test broadly applicable clinical technologies addressing urgent military health needs through translational research and early-phase clinical trials. Multi-PI teams will advance platform products that benefit Service Members, Veterans, and their families.

DoD seeks clinical trial research to advance treatment and management of military-relevant diseases. This peer-reviewed program funds trials from early-phase (Phase 0/1) through large-scale Phase 3 studies, with optional planning support for regulatory preparation.

NSF seeks fundamental research advancing knowledge of STEM education across learning environments, broadening participation, and workforce development. Projects should generate foundational insights with potential long-term impact on educational practice across all learner groups and ages.

The Army seeks data science innovations to advance prostate cancer research and treatment outcomes. This award supports novel analytical approaches and computational methods to improve military health and civilian medical care.

The Army seeks innovative melanoma research proposals to advance understanding of this deadly cancer and improve prevention, detection, and treatment strategies. This program funds early-stage ideas with potential to transform melanoma care and soldier health outcomes.

Support innovative research into rare melanoma subtypes to advance understanding of disease mechanisms and develop targeted treatment strategies. This Army-sponsored program funds basic and translational research addressing an underexplored cancer area with significant clinical impact.

DoD seeks innovative, high-risk autism research to accelerate discoveries and improve outcomes for autistic individuals. This award supports novel ideas with potential to generate impactful data and open new investigation pathways.

The Army seeks collaborative melanoma research teams to advance understanding and treatment of melanoma through innovative scientific approaches. This team science award supports competitive research that addresses critical gaps in melanoma biology and clinical outcomes.

Support clinical trials evaluating new treatments, devices, and approaches for autism management. Awards fund proof-of-concept through large-scale efficacy studies, with funding incentives for early-career researchers partnering with experienced mentors.

Support early-career researchers conducting innovative autism studies and proof-of-principle clinical trials. This award funds high-impact research ideas with required community partnership to advance autism understanding and treatment.

This Army Medical Research funding supports translational research addressing health impacts from toxic exposures on military personnel. Projects bridge discovery science to clinical solutions for affected service members and veterans.

The Army seeks innovative technologies and therapeutic approaches to treat severe burn injuries in military personnel. This award funds development of novel burn treatment solutions from basic research through clinical application.

This award funds translational research bridging discoveries in traumatic brain injury (TBI) and psychological health toward clinical applications. Research aims to advance understanding and treatment of TBI-related mental health conditions in military populations.

This Army funding opportunity supports investigator-initiated research into toxic exposures affecting military personnel, seeking novel scientific studies to understand health impacts and inform prevention strategies.

This Army award supports melanoma survivorship research, focusing on improving quality of life and long-term outcomes for cancer survivors. It seeks studies addressing post-treatment complications, psychosocial factors, and evidence-based interventions for melanoma patients.

The Army seeks patient-centered research to advance burn treatment and recovery outcomes for military personnel. This funding supports innovative clinical studies and therapeutic approaches to improve care for burn-injured soldiers.

This Army research award supports early-stage investigators studying prostate cancer biology, prevention, or treatment. It funds novel scientific research to advance understanding and clinical outcomes for this disease.

The Army seeks innovative research on military burn treatment and prevention through discovery-phase awards. This funding targets novel solutions to improve clinical outcomes for service members with severe thermal injuries.

This Army Medical Research Acquisition Activity (USAMRAA) award supports physician-led research to advance prostate cancer prevention, detection, and treatment. It funds innovative scientific investigations addressing this significant military and public health challenge.

The Army seeks melanoma research to advance understanding and treatment of this serious cancer. This Scholar Award supports innovative scientific studies that could improve patient outcomes and military medical capabilities.

The Army seeks clinical trial research to advance traumatic brain injury and psychological health treatments for service members. This funding supports evidence-based interventions to improve diagnosis, prevention, and recovery outcomes.

The Army seeks innovative prostate cancer research to advance detection, prevention, or treatment approaches. This Idea Development Award funds early-stage scientific studies addressing unmet clinical needs in prostate cancer management.